Modulation of mast cell proliferative and inflammatory responses by leukotriene D4 and stem cell factor signaling interactions

Journal of Cellular Physiology

Volumn 230, Issue 3, 2015, Pages 595-602

  Al Azzam, Nosayba ^a   Kondeti, Vinay ^a   Duah, Ernest ^a   Gombedza, Farai ^a   Thodeti, Charles K ^b   Paruchuri, Sailaja ^a  

^a UNIVERSITY OF AKRON   (United States)

^b Northeast Ohio Medical University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CYCLOOXYGENASE 2; LEUKOTRIENE C4; LEUKOTRIENE D4; LEUKOTRIENE E4; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; RNA; STEM CELL FACTOR; TUMOR NECROSIS FACTOR ALPHA; VERLUKAST; CALCIUM; CYSTEINYL LEUKOTRIENE RECEPTOR 2; LEUKOTRIENE D4 RECEPTOR; LEUKOTRIENE RECEPTOR; STEM CELL FACTOR RECEPTOR;

AIRWAY; ANIMAL CELL; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; CALCIUM TRANSPORT; CELL ACTIVATION; CELL HYPERPLASIA; CELL LYSATE; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; EFFECTOR CELL; HOMEOSTASIS; HUMAN; HUMAN CELL; INFLAMMATION; MAST CELL; MASTOCYTOSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING; DRUG EFFECTS; GENETICS; METABOLISM; PATHOLOGY; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

CALCIUM; CELL PROLIFERATION; HUMANS; INFLAMMATION; LEUKOTRIENE D4; MAST CELLS; MASTOCYTOSIS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-KIT; RECEPTORS, LEUKOTRIENE; SIGNAL TRANSDUCTION; STEM CELL FACTOR;

EID: 84920903653     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24777     Document Type: Article

References (42)

1. Ali K, Bilancio A, Thomas M, Pearce W, Gilfillan AM, Tkaczyk C, Kuehn N, Gray A, Giddings J, Peskett E, Fox R, Bruce I, Walker C, Sawyer C, Okkenhaug K, Finan P, Vanhaesebroeck B. 2004. Essential role for the p110δ phosphoinositide 3-kinase in the allergic response. Nature 431:1007-1011.
2. Blume-Jensen P, Ronnstrand L, Gout I, Waterfield MD, Heldin CH. 1994. Modulation of Kit/stem cell factor receptor-induced signaling by protein kinase C. J Biol Chem 269:21793-21802.
3. Blume-Jensen P, Siegbahn A, Stabel S, Heldin CH, Ronnstrand L. 1993. Increased Kit/SCF receptor induced mitogenicity but abolished cell motility after inhibition of protein kinase C. Embo J 12:4199-4209.
4. Campbell E, Hogaboam C, Lincoln P, Lukacs NW. 1999. Stem cell factor-induced airway hyperreactivity in allergic and normal mice. Am J Pathol 154:1259-1265.
5. Davidson AB, Lee TH, Scanlon PD, Solway J, McFadden ER, Jr., Ingram RH, Jr., Corey EJ, Austen KF, Drazen JM. 1987. Bronchoconstrictor effects of leukotriene E4 in normal and asthmatic subjects. Am Rev Respir Dis 135:333-337.
6. Drazen JM, Austen KF. 1987. Leukotrienes and airway responses. Am Rev Respir Dis 136:985-998.
7. Duah E, Adapala RK, Al-Azzam N, Kondeti V, Gombedza F, Thodeti CK, Paruchuri S. 2013. Cysteinyl leukotrienes regulate endothelial cell inflammatory and proliferative signals through CysLT(2) and CysLT(1) receptors. Sci Rep 3:3274.
8. Galli SJ, Tsai M, Wershil BK, Tam SY, Costa JJ. 1995. Regulation of mouse and human mast cell development, survival and function by stem cell factor, the ligand for the c-kit receptor. Int Arch Allergy Immunol 107:51-53.
9. Gilfillan AM, Tkaczyk C. 2006. Integrated signalling pathways for mast-cell activation. Nat Rev Immunol 6:218-230.
10. Grimbaldeston MA, Metz M, Yu M, Tsai M, Galli SJ. 2006. Effector and potential immunoregulatory roles of mast cells in IgE-associated acquired immune responses. Curr Opin Immunol 18:751-760.
11. Gurish MF, Boyce JA. 2006. Mast cells: Ontogeny, homing, and recruitment of a unique innate effector cell. J Allergy Clin Immunol 117:1285-1291.
12. Heise CE, O'Dowd BF, Figueroa DJ, Sawyer N, Nguyen T, Im DS, Stocco R, Bellefeuille JN, Abramovitz M, Cheng R, Williams DL, Jr., Zeng Z, Liu Q, Ma L, Clements MK, Coulombe N, Liu Y, Austin CP, George SR, O'Neill GP, Metters KM, Lynch KR, Evans JF. 2000. Characterization of the human cysteinyl leukotriene 2 receptor. J Biol Chem 275:30531-30536.
13. Hundley TR, Gilfillan AM, Tkaczyk C, Andrade MV, Metcalfe DD, Beaven MA. 2004. Kit and FcepsilonRI mediate unique and convergent signals for release of inflammatory mediators from human mast cells. Blood 104:2410-2417.
14. Iemura A, Tsai M, Ando A, Wershil BK, Galli SJ. 1994. The c-kit ligand, stem cell factor, promotes mast cell survival by suppressing apoptosis. Am J Pathol 144:321-328.
15. Ito T, Smrz D, Jung MY, Bandara G, Desai A, Smrzova S, Kuehn HS, Beaven MA, Metcalfe DD, Gilfillan AM. 2012. Stem cell factor programs the mast cell activation phenotype. J Immunol 188:5428-5437.
16. Jensen BM, Beaven MA, Iwaki S, Metcalfe DD, Gilfillan AM. 2008. Concurrent inhibition of kit- and FcepsilonRI-mediated signaling: Coordinated suppression of mast cell activation. J Pharmacol Exp Ther 324:128-138.
17. Jensen BM, Metcalfe DD, Gilfillan AM. 2007. Targeting kit activation: A potential therapeutic approach in the treatment of allergic inflammation. Inflamm Allergy Drug Targets 6:57-62.
18. Jiang Y, Kanaoka Y, Feng C, Nocka K, Rao S, Boyce JA. 2006. Cutting edge: Interleukin 4-dependent mast cell proliferation requires autocrine/intracrine cysteinyl leukotriene-induced signaling. J Immunol 177:2755-2759.
19. Kanaoka Y, Boyce JA. 2004. Cysteinyl leukotrienes and their receptors: Cellular distribution and function in immune and inflammatory responses. J Immunol 173:1503-1510.
20. Kim DC, Hsu FI, Barrett NA, Friend DS, Grenningloh R, Ho IC, Al-Garawi A, Lora JM, Lam BK, Austen KF, Kanaoka Y. 2006. Cysteinyl leukotrienes regulate Th2 cell-dependent pulmonary inflammation. J Immunol 176:4440-4448.
21. Kirshenbaum AS, Akin C, Wu Y, Rottem M, Goff JP, Beaven MA, Rao VK, Metcalfe DD. 2003. Characterization of novel stem cell factor responsive human mast cell lines LAD 1 and 2 established from a patient with mast cell sarcoma/leukemia; activation following aggregation of FcεRI or FcγRI. Leuk Res 27:677-682.
22. Kirshenbaum AS, Goff JP, Semere T, Foster B, Scott LM, Metcalfe DD. 1999. Demonstration that human mast cells arise from a progenitor cell population that is CD34(+), c-kit(+), and expresses aminopeptidase N (CD13). Blood 94:2333-2342.
23. Kondeti V, Duah E, Al-Azzam N, Thodeti CK, Boyce JA, Paruchuri S. 2013. Differential regulation of cysteinyl leukotriene receptor signaling by protein kinase C in human mast cells. PLoS One 8:e71536.
24. Laidlaw TM, Steinke JW, Tinana AM, Feng C, Xing W, Lam BK, Paruchuri S, Boyce JA, Borish L. 2011. Characterization of a novel human mast cell line that responds to stem cell factor and expresses functional FcεRI. J Allergy Clin Immunol 127:815-822.
25. Lynch KR, O'Neill GP, Liu Q, Im DS, Sawyer N, Metters KM, Coulombe N, Abramovitz M, Figueroa DJ, Zeng Z, Connolly BM, Bai C, Austin CP, Chateauneuf A, Stocco R, Greig GM, Kargman S, Hooks SB, Hosfield E, Williams DL, Jr., Ford-Hutchinson AW, Caskey CT, Evans JF. 1999. Characterization of the human cysteinyl leukotriene CysLT1 receptor. Nature 399:789-793.
26. Mani M, Venkatasubrahmanyam S, Sanyal M, Levy S, Butte A, Weinberg K, Jahn T. 2009. Wiskott-Aldrich syndrome protein is an effector of Kit signaling. Blood 114:2900-2908.
27. Mellor EA, Austen KF, Boyce JA. 2002. Cysteinyl leukotrienes and uridine diphosphate induce cytokine generation by human mast cells through an interleukin 4-regulated pathway that is inhibited by leukotriene receptor antagonists. J Exp Med 195:583-592.
28. Mellor EA, Frank N, Soler D, Hodge MR, Lora JM, Austen KF, Boyce JA. 2003. Expression of the type 2 receptor for cysteinyl leukotrienes (CysLT2R) by human mast cells: Functional distinction from CysLT1R. Proc Natl Acad Sci USA 100:11589-11593.
29. Mellor EA, Maekawa A, Austen KF, Boyce JA. 2001. Cysteinyl leukotriene receptor 1 is also a pyrimidinergic receptor and is expressed by human mast cells. Proc Natl Acad Sci USA 98:7964-7969.
30. Metcalfe DD, Baram D, Mekori YA. 1997. Mast cells. Physiol Rev 77:1033-1079.
31. Moller C, Alfredsson J, Engstrom M, Wootz H, Xiang Z, Lennartsson J, Jonsson JI, Nilsson G. 2005. Stem cell factor promotes mast cell survival via inactivation of FOXO3a-mediated transcriptional induction and MEK-regulated phosphorylation of the proapoptotic protein Bim. Blood 106:1330-1336.
32. Okayama Y, Kawakami T. 2006. Development, migration, and survival of mast cells. Immunol Res 34:97-115.
33. Oliveira SH, Hogaboam CM, Berlin A, Lukacs NW. 2001. SCF-induced airway hyperreactivity is dependent on leukotriene production. Am J Physiol Lung Cell Mol Physiol 280:L1242-L1249.
34. Paruchuri S, Hallberg B, Juhas M, Larsson C, Sjolander A. 2002. Leukotriene D(4) activates MAPK through a Ras-independent but PKCε-dependent pathway in intestinal epithelial cells. J Cell Sci 115:1883-1893.
35. Paruchuri S, Jiang Y, Feng C, Francis SA, Plutzky J, Boyce JA. 2008. Leukotriene E4 activates peroxisome proliferator-activated receptor γand induces prostaglandin D2 generation by human mast cells. J Biol Chem 283:16477-16487.
36. Paruchuri S, Tashimo H, Feng C, Maekawa A, Xing W, Jiang Y, Kanaoka Y, Conley P, Boyce JA. 2009. Leukotriene E4-induced pulmonary inflammation is mediated by the P2Y12 receptor. J Exp Med 206:2543-2555.
37. Prussin C, Metcalfe DD. 2006. 5. IgE, mast cells, basophils, and eosinophils. J Allergy Clin Immunol 117:S450-S456.
38. Raithel M, Zopf Y, Kimpel S, Naegel A, Molderings GJ, Buchwald F, Schultis HW, Kressel J, Hahn EG, Konturek P. 2011. The measurement of leukotrienes in urine as diagnostic option in systemic mastocytosis. J Physiol Pharmacol 62:469-472.
39. Smrz D, Bandara G, Beaven MA, Metcalfe DD, Gilfillan AM. 2013. Prevention of F-actin assembly switches the response to SCF from chemotaxis to degranulation in human mast cells. Eur J Immunol 43:1873-1882.
40. Tkaczyk C, Jensen BM, Iwaki S, Gilfillan AM. 2006. Adaptive and innate immune reactions regulating mast cell activation: from receptor-mediated signaling to responses. Immunol Allergy Clin North Am 26:427-450.
41. Tsai M, Takeishi T, Thompson H, Langley KE, Zsebo KM, Metcalfe DD, Geissler EN, Galli SJ. 1991. Induction of mast cell proliferation, maturation, and heparin synthesis by the rat c-kit ligand, stem cell factor. Proc Natl Acad Sci USA 88:6382-6386.
42. Wedemeyer J, Tsai M, Galli SJ. 2000. Roles of mast cells and basophils in innate and acquired immunity. Curr Opin Immunol 12:624-631.